Gara Jalqabaatti › Sarcoma Sinoviyaal
Qorannoo klinikaalii Sarcoma Sinoviyaal Ameerikaa Keessatti hirmaatuu
Qorannoo 13 Sarcoma Sinoviyaal f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- Boston, MAQorannoo 5
- Chicago, ILQorannoo 4
- Houston, TXQorannoo 4
- New York City, NYQorannoo 3
- St. Louis, MOQorannoo 3
Naannoon
- CaliforniaQorannoo 5
- IllinoisQorannoo 4
- MassachusettsQorannoo 5
- MissouriQorannoo 3
- New YorkQorannoo 3
- PennsylvaniaQorannoo 3
- TexasQorannoo 4
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT05711615First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT06644755N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy
Namoota walitti qabaa jiraSadarkaa jalqabaa 1
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 27-Hag-2026 · NCT07261657SPEARHEAD-3 Pediatric Study
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 2 hanga 21 · Saalaa hunda · Haaromfame 11-Hag-2026 · NCT05642455NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
Namoota walitti qabaa jiraSadarkaa 1/2
Hanga umuriin 30 · Saalaa hunda · Haaromfame 03-Hag-2026 · NCT06239272Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 16 hanga 80 · Saalaa hunda · Haaromfame 29-Ado-2026 · NCT06083883AOH1996 for the Treatment of Refractory Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ado-2026 · NCT05227326Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
6 Months – 25 Years · Saalaa hunda · Haaromfame 30-Wax-2026 · NCT06625190XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma, Bone Sarcoma or Translocation-associated Soft Tissue Sarcoma
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Wax-2026 · NCT06571734Synovial Sarcoma Registry / Biospecimen Repository
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 09-Wax-2026 · NCT05910307Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Gur-2026 · NCT03016819HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 1 hanga 25 · Saalaa hunda · Haaromfame 22-Ama-2026 · NCT04995003ACTengine® IMA203 Combined With mRNA-4203
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Ama-2026 · NCT06946225Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.